Published in Przegl Lek on January 01, 2007
Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med (2011) 1.20
Polymorphism of the renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transplant (2011) 1.01
Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant (2005) 0.96
Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol (2003) 0.94
Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Hum Immunol (2009) 0.94
TGF-beta1 and TSC-22 gene polymorphisms and susceptibility to microvascular complications in type 2 diabetes. Nephron Physiol (2007) 0.93
Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant (2004) 0.88
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients. Cytokine (2008) 0.87
The investigation of Staphylococcus aureus and coagulase-negative staphylococci nasal carriage among patients undergoing haemodialysis. Microbiol Res (2005) 0.86
Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients. Diabetes Res Clin Pract (2011) 0.85
Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis. Pol Arch Med Wewn (2010) 0.85
Endothelial nitric oxide synthase gene intron 4 polymorphism in non-traumatic osteonecrosis of the femoral head. Int Orthop (2013) 0.83
Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes. Clin Sci (Lond) (2009) 0.83
Effect of haemodialysis on regional and transmural inhomogeneities of the ventricular repolarisation phase. Nephron Clin Pract (2005) 0.82
Nutrition and hydration status improve with exercise training using stationary cycling during hemodialysis (HD) in patients with end-stage renal disease (ESRD). Ann Univ Mariae Curie Sklodowska Med (2002) 0.82
Monocyte chemoattractant protein (MCP-1) A-2518G gene polymorphism in stroke patients with different comorbidities. Clin Biochem (2010) 0.82
Aortic stiffness and valvular calcifications in patients with end-stage renal disease. Pol Arch Med Wewn (2008) 0.81
Spatial QRS-T angle in peritoneal dialysis patients: association with carotid artery atherosclerosis, coronary artery calcification and troponin T. Nephrol Dial Transplant (2008) 0.80
Characterisation of Staphylococcus aureus nasal and skin carriage among patients undergoing haemodialysis treatment. New Microbiol (2007) 0.80
Influence of the hepatocellular damage on the clinical usefulness of biochemical markers of bone metabolism and parathormon in haemodialysed patients. Med Sci Monit (2002) 0.79
[Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. Pol Arch Med Wewn (2002) 0.79
Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients. Ren Fail (2007) 0.79
Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Nephron (2002) 0.79
Effect of haemodialysis on signal-averaged electrocardiogram P-wave parameters. Nephrol Dial Transplant (2005) 0.78
[Femoral neck fractures in hemodialysis patients]. Przegl Lek (2003) 0.78
Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure. Clin Chem Lab Med (2006) 0.78
Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland. BMC Musculoskelet Disord (2013) 0.78
The intercellular adhesion molecule-1 (ICAM-1) gene polymorphism K469E in end-stage renal disease patients with cardiovascular disease. Hum Immunol (2012) 0.78
Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant (2004) 0.78
Concentrations of branched amino acids: isoleucine, valine, leucine in serum of hemodialysis patients during one-year observation. Ann Univ Mariae Curie Sklodowska Med (2002) 0.77
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in Poland: further evidence for the changing epidemiology of MRSA. New Microbiol (2008) 0.77
A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients. Ren Fail (2006) 0.77
Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy. Ren Fail (2004) 0.77
Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure. Leuk Res (2012) 0.76
[Skeletal scintigraph and some bone turnover markers in the diagnosis of renal osteodystrophy in hemodialysis patients]. Pol Arch Med Wewn (2003) 0.76
[Analysis of some risk factors of coronary artery calcification in peritoneal dialysis patients]. Pol Arch Med Wewn (2006) 0.76
Phosphate Kinetics in Hemodialysis: Application of Delayed Pseudo One-Compartment Model. Blood Purif (2016) 0.75
[Clinical analysis of CAPD-treated patients without anemia]. Wiad Lek (2003) 0.75
Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Factors producing increase of QRS complex amplitude during hemodialysis]. Przegl Lek (2005) 0.75
Effect of acetate and bicarbonate dialysate on whole body bioimpedance (BIS) and segmental (thoracic) bioimpedance in hemodialysed (HD) patients. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Urologic complications as a reason of recurrent urinary tract infections in patients after renal transplantation]. Wiad Lek (2004) 0.75
The -308 promoter polymorphism in the tumour necrosis factor gene in patients with lichen planus. Acta Derm Venereol (2005) 0.75
[Secondary amyloidosis connected with neoplasma of urinary bladder and acquired disorders of blood coagulation. Case report]. Pol Arch Med Wewn (2006) 0.75
Discontinuation of mycophenolate mofetil from a tacrolimus-based triple regimen 2 months after renal transplantation: a comparative randomized, multicentre study. Transpl Int (2007) 0.75
Care provided for hemodialysis patients in selected dialysis centres of the Lublin region. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Whole body versus segmental bioimpedance measurements (BIS) of electrical resistance (Re) and extracellular volume (ECV) for assessment of dry weight in end-stage renal patients treated by hemodialysis]. Przegl Lek (2004) 0.75
[Influence of hemodialysis on the homogenicity of repolarization phase of action potential of myocardium]. Pol Merkur Lekarski (2002) 0.75
[Can human recombinant erythropoietin (rHuEPO) be considered as cardiological medicine?]. Przegl Lek (2005) 0.75
Sialic acid content in erythrocyte membranes of patients on chronic hemodialysis. Pol Arch Med Wewn (2009) 0.75
[Factors influencing signal-averaged ECG parameters in hemodialysis patients]. Przegl Lek (2005) 0.75
Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease. Mol Diagn Ther (2007) 0.75
[Hemolytic uremic syndrome]. Pol Arch Med Wewn (2005) 0.75
Comparison between some anthropometric measurements in adequately treated peritoneal dialysis and hemodialysis patients. Ann Univ Mariae Curie Sklodowska Med (2004) 0.75
How are hemodialysis patients treated in the Lublin region--based on the selected issues of diagnosis and therapy. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[28-year-old woman with Goodpasture's syndrome and nonspecific colitis]. Pol Arch Med Wewn (2004) 0.75
Hypercalcemia in patients treated with CAPD. Ann Univ Mariae Curie Sklodowska Med (2004) 0.75
[Prevalence of depressive disorders in patients with end-stage renal failure]. Psychiatr Pol (2011) 0.75
[Pseudo-Bartter syndrome--2 cases]. Przegl Lek (2010) 0.75
Comparison of lipid and lipoprotein profiles in long-term chronic ambulatory peritoneal dialysis (CAPD) in elderly patients with chronic renal failure (CRF). Int Urol Nephrol (2002) 0.75
Adequacy of hemodialysis. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
[Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R]. Pol Merkur Lekarski (2014) 0.75
[Are there relationship between Helicobacter pylori infection and gastrin levels in long term hemodialysed patients?]. Przegl Lek (2002) 0.75
[Changes in selected parameters of bone turnover resulting from use of different calcium concentrations in dialysate of patients treated with CAPD]. Pol Arch Med Wewn (2004) 0.75
Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis. Mol Diagn (2003) 0.75
[Comparison of some nutritional parameters in hemodialysis patients over and below 65 years of age]. Pol Arch Med Wewn (2005) 0.75
[Some aspects of homocysteine metabolism in hemodialysis patients]. Pol Arch Med Wewn (2002) 0.75
[Polymorphism of angiotensin II type 1 receptor in terminal renal failure]. Pol Merkur Lekarski (2002) 0.75
Changes of extracellular volumes measured by whole and segmental bioimpedance analysis during hemodialysis in end-stage renal disease (ESRD) patients. Ann Univ Mariae Curie Sklodowska Med (2002) 0.75
Effect of prostaglandin E1 on peritoneal membrane transport in CAPD-treated diabetic patients. Perit Dial Int (2008) 0.75
[Acute cardiac failure secondary to brachiocephalic arteriovenous fistula in patient on chronic haemodialysis]. Pol Arch Med Wewn (2004) 0.75
Comparison of prescribed and delivered doses of dialysis using anthropometrically and bioelectrically measured patient volumes. Med Sci Monit (2003) 0.75